Index S&P 500
P/E 32.51
EPS (ttm) 15.26
Insider Own 0.17%
Shs Outstand 390.51M
Perf Week 1.09%
Market Cap 191.69B
Forward P/E 22.67
EPS next Y 21.89
Insider Trans -12.67%
Shs Float 385.73M
Perf Month 12.47%
Income 5.94B
PEG 15.48
EPS next Q 5.64
Inst Own 90.34%
Short Float / Ratio 0.70% / 1.50
Perf Quarter -10.96%
Sales 43.42B
P/S 4.41
EPS this Y -7.31%
Inst Trans 0.05%
Short Interest 2.72M
Perf Half Y -4.62%
Book/sh 117.32
P/B 4.23
EPS next Y 1.61%
ROA 6.33%
Target Price 516.73
Perf Year -11.44%
Cash/sh 15.95
P/C 31.11
EPS next 5Y 2.10%
ROE 13.37%
52W Range 415.60 - 609.85
Perf YTD -9.91%
Dividend 1.37
P/FCF 29.28
EPS past 5Y 25.84%
ROI 7.84%
52W High -18.65%
Beta 0.83
Dividend % 0.28%
Quick Ratio 1.25
Sales past 5Y 16.74%
Gross Margin 39.02%
52W Low 19.38%
ATR 10.66
Employees 130000
Current Ratio 1.63
Sales Q/Q -0.96%
Oper. Margin 17.14%
RSI (14) 64.88
Volatility 1.52% 1.86%
Optionable Yes
Debt/Eq 0.78
EPS Q/Q 16.79%
Profit Margin 13.68%
Rel Volume 0.67
Prev Close 495.76
Shortable Yes
LT Debt/Eq 0.67
Earnings Oct 25 BMO
Payout 6.80%
Avg Volume 1.81M
Price 496.13
Recom 1.63
SMA20 5.88%
SMA50 4.43%
SMA200 -5.46%
Volume 1,207,366
Change 0.07%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-26-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Oct-25-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$52 → $475
Sep-28-23 Initiated
Bernstein
Outperform
$603
Sep-06-23 Resumed
Citigroup
Buy
$625
Jul-19-23 Reiterated
Robert W. Baird
Outperform
$670 → $664
Jul-19-23 Initiated
Raymond James
Outperform
$595
Jul-13-23 Upgrade
Credit Suisse
Neutral → Outperform
$620
Apr-04-23 Reiterated
Barclays
Overweight
$660 → $625
Dec-14-22 Initiated
Deutsche Bank
Buy
$620
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$661
Oct-27-22 Downgrade
The Benchmark Company
Buy → Hold
Aug-25-22 Initiated
Credit Suisse
Neutral
$675
Apr-25-22 Downgrade
Wells Fargo
Equal Weight → Underweight
$525
Jan-26-22 Resumed
Barclays
Overweight
$700
Oct-20-21 Upgrade
Citigroup
Neutral → Buy
$620 → $700
Oct-15-21 Resumed
Cowen
Outperform
$655 → $696
Aug-05-21 Resumed
Credit Suisse
Outperform
$580
Jul-16-21 Initiated
The Benchmark Company
Buy
$580
Mar-18-21 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
Mar-03-21 Initiated
Barclays
Overweight
$525
Show Previous Ratings
Dec-01-23 08:00AM
Nov-30-23 02:30PM
11:51AM
Nov-29-23 05:32PM
Nov-28-23 08:13PM
08:00AM
Loading…
08:00AM
Nov-26-23 05:56AM
Nov-24-23 11:31AM
03:19AM
Nov-21-23 06:02AM
Nov-20-23 06:52AM
Nov-18-23 12:16PM
Nov-14-23 09:26AM
08:00AM
Nov-13-23 02:18PM
05:00PM
Loading…
Nov-09-23 05:00PM
Nov-08-23 08:54AM
Nov-07-23 06:02AM
Nov-05-23 07:08AM
Nov-03-23 09:37AM
08:37AM
05:20AM
05:00AM
Nov-01-23 08:34AM
08:16AM
Oct-31-23 08:43AM
Oct-30-23 09:50AM
05:57AM
Oct-26-23 11:11AM
09:56AM
11:26PM
Loading…
Oct-25-23 11:26PM
(Thomson Reuters StreetEvents) -5.47%
04:15PM
04:04PM
(Investor's Business Daily)
02:00PM
01:41PM
12:21PM
(American City Business Journals)
12:21PM
(American City Business Journals)
12:17PM
(Associated Press Finance)
12:09PM
11:44AM
10:42AM
09:30AM
09:12AM
09:03AM
(Investor's Business Daily)
08:02AM
07:15AM
06:45AM
06:13AM
(Associated Press Finance)
06:09AM
06:08AM
06:04AM
06:00AM
04:15AM
Oct-24-23 08:01AM
Oct-19-23 06:00PM
10:01AM
Oct-18-23 11:00AM
10:01AM
09:52AM
Oct-17-23 05:19PM
11:29AM
09:02AM
08:52AM
08:49AM
08:19AM
Oct-16-23 08:13AM
Oct-13-23 06:00PM
08:00AM
Oct-11-23 06:18AM
Oct-10-23 10:10AM
08:38AM
Oct-09-23 01:23PM
Oct-06-23 06:00PM
07:48AM
Oct-05-23 06:15PM
Oct-03-23 12:03PM
08:00AM
Oct-02-23 11:28AM
Sep-29-23 06:00PM
04:05PM
Sep-28-23 09:49AM
Sep-26-23 06:15PM
Sep-24-23 07:10PM
Sep-20-23 06:00PM
02:00AM
Sep-19-23 11:01AM
Sep-18-23 06:15PM
Sep-17-23 05:36PM
05:30AM
(The Wall Street Journal)
Sep-12-23 06:00PM
Sep-11-23 11:39AM
Sep-08-23 07:04PM
01:03PM
08:04AM
Sep-07-23 08:00AM
Sep-06-23 06:00PM
11:14AM
09:36AM
08:00AM
Aug-31-23 06:00PM
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CASPER MARC N Chairman & CEO Nov 07 Option Exercise 157.68 1,600 252,288 132,775 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 07 Sale 460.25 1,600 736,404 131,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 06 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 06 Sale 454.41 10,000 4,544,053 131,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 03 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 03 Sale 456.15 10,000 4,561,459 131,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 02 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 02 Sale 445.49 10,000 4,454,880 131,175 Nov 06 04:34 PM Pettiti Gianluca Executive Vice President Aug 30 Option Exercise 253.99 3,000 761,970 20,556 Aug 31 04:15 PM Pettiti Gianluca Executive Vice President Aug 30 Sale 557.77 3,000 1,673,310 17,556 Aug 31 04:15 PM CASPER MARC N Chairman & CEO Aug 08 Option Exercise 157.68 1,600 252,288 136,930 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 08 Sale 550.60 1,600 880,960 135,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 07 Option Exercise 157.68 10,000 1,576,800 145,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 07 Sale 551.94 10,000 5,519,370 135,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 04 Option Exercise 157.68 10,000 1,576,800 145,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 04 Sale 550.33 10,000 5,503,317 135,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 03 Option Exercise 157.68 10,000 1,576,800 151,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 03 Sale 549.00 10,000 5,490,050 141,330 Aug 07 04:05 PM Williamson Stephen Sr. VP and CFO Aug 01 Option Exercise 190.59 14,100 2,687,319 41,493 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Aug 01 Sale 550.00 14,100 7,755,000 27,393 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Jul 31 Option Exercise 190.59 15,000 2,858,850 42,393 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Jul 31 Sale 557.42 15,000 8,361,300 27,393 Aug 02 04:33 PM Boxer Michael A SVP and General Counsel Jun 26 Buy 526.15 4 2,105 13,101 Oct 06 04:23 PM CASPER MARC N Chairman & CEO May 09 Option Exercise 157.68 1,600 252,288 142,930 May 10 04:13 PM CASPER MARC N Chairman & CEO May 09 Sale 534.82 1,600 855,710 141,330 May 10 04:13 PM CASPER MARC N Chairman & CEO May 08 Option Exercise 157.68 10,000 1,576,800 151,330 May 10 04:13 PM CASPER MARC N Chairman & CEO May 08 Sale 544.40 10,000 5,444,003 141,330 May 10 04:13 PM CASPER MARC N Chairman & CEO May 05 Option Exercise 157.68 10,000 1,576,800 151,330 May 08 04:21 PM CASPER MARC N Chairman & CEO May 05 Sale 545.22 10,000 5,452,236 141,330 May 08 04:21 PM CASPER MARC N Chairman & CEO May 04 Option Exercise 157.68 10,000 1,576,800 151,330 May 08 04:21 PM CASPER MARC N Chairman & CEO May 04 Sale 546.98 10,000 5,469,779 141,330 May 08 04:21 PM CASPER MARC N Chairman & CEO Mar 14 Sale 553.79 7,500 4,153,452 59,155 Mar 15 04:07 PM CASPER MARC N Chairman & CEO Mar 13 Sale 544.49 7,500 4,083,693 66,655 Mar 15 04:07 PM CASPER MARC N Chairman & CEO Feb 14 Option Exercise 157.68 1,600 252,288 130,305 Feb 15 04:20 PM CASPER MARC N Chairman & CEO Feb 14 Sale 571.96 1,600 915,132 128,705 Feb 15 04:20 PM CASPER MARC N Chairman & CEO Feb 13 Option Exercise 157.68 10,000 1,576,800 138,705 Feb 15 04:20 PM CASPER MARC N Chairman & CEO Feb 13 Sale 574.48 10,000 5,744,836 128,705 Feb 15 04:20 PM CASPER MARC N Chairman & CEO Feb 10 Option Exercise 157.68 10,000 1,576,800 148,705 Feb 13 04:35 PM CASPER MARC N Chairman & CEO Feb 10 Sale 569.18 20,000 11,383,631 128,705 Feb 13 04:35 PM CASPER MARC N Chairman & CEO Feb 09 Option Exercise 157.68 10,000 1,576,800 158,705 Feb 13 04:35 PM CASPER MARC N Chairman & CEO Feb 09 Sale 575.43 20,000 11,508,662 138,705 Feb 13 04:35 PM MANZI JIM P Director Feb 03 Sale 584.56 1,000 584,559 14,807 Feb 07 04:11 PM Spar Debora L Director Dec 15 Sale 561.39 200 112,278 979 Dec 16 04:15 PM Pettiti Gianluca Executive Vice President Dec 14 Sale 569.11 2,000 1,138,220 14,450 Dec 15 05:39 PM Pettiti Gianluca Executive Vice President Dec 13 Option Exercise 210.68 4,975 1,048,133 21,425 Dec 15 05:39 PM Pettiti Gianluca Executive Vice President Dec 13 Sale 576.84 4,975 2,869,779 16,450 Dec 15 05:39 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite